Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing awareness regarding canine health
3.2.1.2 Growing cases of arthritis and related disorders
3.2.1.3 Advancement in technology for treatment
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of treatment
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter's analysis
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Treatment Type, 2021 – 2032 ($ Million)
5.1 Key trends
5.2 Drugs
5.2.1 Non-steroidal anti-inflammatory drugs (NSAID’s)
5.2.2 Corticosteroids
5.2.3 Opioid pain relievers
5.2.4 Other drugs
5.3 Supplements
5.3.1 Glucosamine
5.3.2 Chondroitin
5.3.3 Methylsulfonylmethane
5.3.4 Other supplements
5.3.5 Drugs and supplements market, by route of administration
5.3.5.1 Oral
5.3.5.2 Injectable
5.3.5.3 Other routes of administration
5.3.6 Drugs and supplements market, by distribution channel
5.3.6.1 Veterinary hospital pharmacies
5.3.6.2 Retail pharmacies
5.3.6.3 Online pharmacies
5.4 Surgical procedures
5.5 Other treatment types
Chapter 6 Market Estimates and Forecast, By Arthritis Type, 2021 – 2032 ($ Million)
6.1 Key trends
6.2 Osteoarthritis
6.3 Osteochondrosis
6.4 Rheumatoid arthritis
6.5 Traumatic arthritis
Chapter 7 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 France
7.3.4 Spain
7.3.5 Italy
7.3.6 Rest of Europe
7.4 Asia Pacific
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Australia
7.4.5 Rest of Asia Pacific
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.5.3 Rest of Latin America
7.6 Middle East and Africa
7.6.1 South Africa
7.6.2 Saudi Arabia
7.6.3 Rest of Middle East and Africa
Chapter 8 Company Profiles
8.1 American Regent, Inc.
8.2 Bayer AG
8.3 Boehringer Ingelheim Animal Health
8.4 CEVA Santé Animale
8.5 Dechra Pharmaceuticals PLC
8.6 Elanco Animal Health
8.7 Nutramax Laboratories Veterinary Sciences, Inc.
8.8 Vetoquinol SA
8.9 VetStem, Inc.
8.10 Virbac
8.11 Zoetis Inc.
